Drug Approval | July 24, 2024
Zydus receives USFDA’s final approval for Valsartan Tablets
The drug will be manufactured at the group's formulation manufacturing facility in Ahmedabad SEZ - II, India
The drug will be manufactured at the group's formulation manufacturing facility in Ahmedabad SEZ - II, India
Zydus receives final approval from USFDA for its NDA Zituvimeta, extended-release tablets
Sacubitril and Valsartan combination is used to treat chronic heart failure in adults
Diroximel Fumarate Delayed-Release Capsules is indicated for the treatment of relapsing forms of multiple sclerosis
Azilsartan Medoxomil and Chlorthalidone Tablets had annual sales of US$ 77.9 mn in the United States (IQVIA MAT March 24).
Shelter Pharma Limited secured an order from Berlin International Medical Co D3Cure 50 ml x 30000 pcs
Theophylline is used to treat asthma and chronic obstructive pulmonary disease
The drug will be manufactured at the group's topical manufacturing facility at Changodar, Ahmedabad (India)
Zydus is among the first suppliers to launch the generic version of Mirabegron Extended-Release Tablets, USP 25 mg in the US market
USFDA inspects Zydus Lifesciences’ Ahmedabad SEZ Onco manufacturing plant
Subscribe To Our Newsletter & Stay Updated
